ANI Pharmaceuticals Provides Update on Closing of Acquisition of Alimera Sciences
Provided By GlobeNewswire
Last update: Sep 10, 2024
PRINCETON, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or “the Company”) (Nasdaq: ANIP) today provided an update on the status of the completion of its previously announced acquisition of Alimera Sciences, Inc. (“Alimera”) (Nasdaq: ALIM).
